Abstract:Ebselen (EBS) is an organo-selenium-containing compound that has anti-inflammatory, antitumor, and antibacterial properties. EBS is being explored as a possible treatment for reperfusion injury and stroke and is under clinical trials as a mimetic of lithium for the treatment of bipolar disorder [Motaet al. Synapse 2020, 74 (7), 1−6] and noise-induced hearing loss as a result of these actives [Martini et al. J. Psychiatr. Res. 2019, 109, 107−117. Slusarczyket al. Neural Regener. Res. 2019, 17 (7), 1255–1261. Thangamaniet al. PLoS One 2015, 10 (7), e0133877. Kil et al. Lancet 2017, 390 (10098), 969–979]. However, we wanted to characterize derivatives of EBS as neuroprotective, anti-neuroinflammatory, and antioxidant compounds. Recently, we have reported on a new thermal and photoinduced copper-mediated cross-coupling between potassium selenocyanate (KSeCN) and N-substituted ortho-halobenzamides to form ebselen derivatives with increased synthetic efficiency [Thanna et al. J. Org. Chem. 2017, 82 (7), 3844−3854]. Our synthesis allows for the varying of the remote benzene ring with various substituents or replacing that ring with heterocyclic rings such as pyridine, pyrrole, thiophene, etc. In this study, we synthesized seven new heterocyclic EBS derivatives to further diversify our EBS library. These 21 compounds were then evaluated for their neuroprotective properties, with four compounds showing an equal or better neuroprotective profile than EBS. Compounds 5, 9, 23, and 27 showed 73, 86, 80, 84% cell viability, respectively, at a 10 μM concentration. These studies were performed using human neuroblastoma SH-SY5Y cells in an oxygen and glucose deprivation (OGD) model of ischemia. At the same concentration, these compounds significantly inhibited lipopolysaccharide-induced nitric oxide and tumor necrosis factor alpha release from Human microglia clone 3 microglial cells. Compounds 9 and 27 showed significantly increased cell viability (84 and 80%, respectively) for SH-SY5Y cells exposed to microglia-activated media. These compounds showed only mild GPx-like reductive activity, with compounds 2, 7, 12, and 14 (115, 96, 95, and 82%, respectively) showing a higher percent rate of oxidation of NADPH in a coupled reaction assay compared to ebselen. This research highlights several derivatives of ebselen that show improved activity as neuroprotective agents over the parent compound.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschemneuro.0c00328?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschemneuro.0c00328</a>.Supporting information include 1H NMR spectra, 13C NMR spectra of compounds 15a–21a and 15–21, and further experimental details (<a class="ext-link" href="/doi/suppl/10.1021/acschemneuro.0c00328/suppl_file/cn0c00328_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Neuroprotective Effects of Ebselen Are Associated with the Regulation of Bcl-2 and Bax Proteins in Cultured Mouse Cortical Neurons

Ebselen Protects Mitochondrial Function and Oxidative Stress While Inhibiting the Mitochondrial Apoptosis Pathway after Acute Spinal Cord Injury.

Neuroprotective and Anti-neuroinflammatory Properties of Ebselen Derivatives and Their Potential to Inhibit Neurodegeneration

Ebselen Interferes with Alzheimer's Disease by Regulating Mitochondrial Function

Cysteine Modification by Ebselen Reduces the Stability and Cellular Levels of 14-3-3 Proteins

Ebselen ameliorates renal ischemia–reperfusion injury via enhancing autophagy in rats

Local Delivery of Β-Elemene Improves Locomotor Functional Recovery by Alleviating Endoplasmic Reticulum Stress and Reducing Neuronal Apoptosis in Rats with Spinal Cord Injury.

Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways

Ebselen Improves Fungal Keratitis Through Exerting Anti-Inflammation, Anti-Oxidative Stress, and Antifungal Effects

[Protective Effects of Breviscapine Against Cultured Rat Hippocampal Neuronal Toxicity Induced by Glutamate].

Effects of ebselen on inflammatory factors in rats with acute lung injury

Protective Effects of Echinacoside, One of the Phenylethanoid Glycosides, on H2O2-Induced Cytotoxicity in PC12 Cells

Regulatory Role and Cytoprotective Effects of Exogenous Recombinant SELENOM under Ischemia-like Conditions and Glutamate Excitotoxicity in Cortical Cells In Vitro

Promotive Effect of Superoxide and Inhibitory Effect of Ebselen on Glutamate Binding to Rat Cortical Synaptosomal Membranes.

Comparison Between the Effects of 2-Selenium Bridged Β-Cyclodextrin and Ebselen on Treating SHRsp Stroke

Features of the cytoprotective effect of selenium nanoparticles on primary cortical neurons and astrocytes during oxygen-glucose deprivation and reoxygenation

Selenoprotein Gene mRNA Expression Evaluation During Renal Ischemia–Reperfusion Injury in Rats and Ebselen Intervention Effects

Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity

Selenepezil, a Selenium-Containing Compound, Exerts Neuroprotective Effect via Modulation of the Keap1-Nrf2-ARE Pathway and Attenuates Aβ-Induced Cognitive Impairment in Vivo.

Hematobiochemical Disturbances and Oxidative Stress After Subacute Manganese Chloride Exposure and Potential Protective Effects of Ebselen in Rats

Evaluation of the Neuroprotective Effect of Organic Selenium Compounds: An in Vitro Model of Alzheimer's Disease